Risk of pituitary tumors in cellular phone users: A case-control study

Epidemiology

Volumn 20, Issue 3, 2009, Pages 348-354

  Schoemaker, Minouk J ^a   Swerdlow, Anthony J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS TUMOR; INTERVIEW; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; TUMOR LOCALIZATION; UNITED KINGDOM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CELLULAR PHONE; ENGLAND; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; ODDS RATIO; PITUITARY NEOPLASMS; RISK ASSESSMENT; YOUNG ADULT;

EID: 66549111612     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31819c7ba8     Document Type: Article

References (38)

1. International Telecommunication Union. Worldwide mobile cellular subscribers to reach 4 billion mark late 2008. http://www.itu.int/newsroom/ press-releases/2008/29.html.
2. Schoemaker MJ, Swerdlow AJ. Epidemiological studies of cellular phone use and risk of cancer. In: Lin JC, ed. Advances in Electromagnetic Fields in Living Systems. Vol 5. New York: Springer-Verlag (in press).
3. SCENIHR (Scientific Committee on Emerging and Newly identified Health Risks). Possible Effects of Electromagnetic Fields (EMF) on Human Health. Brussels: European Commission; 2007.
4. Dimbylow P, Mann SJ. Characterisation of energy deposition in the head from cellular phones. Radiat Prot Dosimetry. 1999;83:139-141.
5. Cardis E, Deltour I, Mann S, et al. Distribution of RF energy emitted by mobile phones in anatomical structures of the brain. Phys Med Biol. 2008;53:2771-2783.
6. Independent Expert Group on Mobile Phones (IEGMP). Mobile Phones and Health. Chilton, Didcot: National Radiological Protection Board; 2000.
7. Health Council of the Netherlands. Mobile Telephones: An Evaluation of Health Effects. The Hague: Health Council of the Netherlands; 2002.
8. AGNIR. Health Effects from Radiofrequency Electromagnetic Fields: Report of an independent Advisory Group of Non-Ionising Radiation. Doc NRPB. 2003;14:1-177.
9. Moulder JE, Foster KR, Erdreich LS, McNamee JP. Mobile phones, mobile phone base stations and cancer: a review. Int J Radiat Biol. 2005;81:189-203.
10. The Royal Society of Canada. Recent Advances in Research on Radio-frequency Fields and Health: 2001-2003. Ottawa, Ontario: The Royal Society of Canada; 2004.
11. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer. 2002;2:836-849.
12. DeLellis R, Lloyd R, Heitz P, et al. pathology and genetics of tumours of endocrine origin. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004:320.
13. Takebayashi T, Varsier N, Kikuchi Y, et al. Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study. Br J Cancer. 2008;98:652-659.
14. Schoemaker MJ, Swerdlow AJ, Ahlbom A, et al. Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in 5 North European countries. Br J Cancer. 2005;93:842-848.
15. Lahkola A, Auvinen A, Raitanen J, et al. Mobile phone use and risk of glioma in 5 North European countries. Int J Cancer. 2007;120:1769-1775.
16. Lahkola A, Salminen T, Raitanen J, et al. Meningioma and mobile phone use - a collaborative case-control study in five North European countries. Int J Epidemiol. 2008;37:1304-1313.
17. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22:647-664.
18. WHO. International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva: World Health Organization; 1992.
19. OPCS. Morbidity Statistics from General Practice; Fourth national study 1991-1992. London: HMSO; 1995.
20. Christensen HC, Schuz J, Kosteljanetz M, et al. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol. 2004;159:277-283.
21. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. New York: Croom Helm; 1988.
22. StataCorp. Stata Statistical Software: Release 9.0. College Station, Texas: Stata Corporation; 2006.
23. Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst. 2002;94:1555-1563.
24. Vrijheid M, Cardis E, Armstrong BK, et al. Validation of short term recall of mobile phone use for the interphone study. Occup Environ Med. 2006;63:237-243.
25. Vrijheid M, Armstrong BK, Bedard D, et al. Recall bias in the assessment of exposure to mobile phones. J Expo Sci Environ Epidemiol. 2008.
26. Lahkola A, Salminen T, Auvinen A. Selection bias due to differential participation in a case-control study of mobile phone use and brain tumors. Ann Epidemiol. 2005;15:321-325.
27. Lonn S, Ahlbom A, Hall P, Feychting M. Mobile phone use and the risk of acoustic neuroma. Epidemiology. 2004;15:653-659.
28. Schuz J, Bohler E, Berg G, et al. Cellular Phones, Cordless Phones, and the Risks of Glioma and Meningioma (Interphone Study Group, Germany). Am J Epidemiol. 2006;163:512-520.
29. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101:613-619.
30. Kameya T, Tsukada T, Yamaguchi K. Recent advances in MEN1 gene study for pituitary tumor pathogenesis. Front Horm Res. 2004; 32:265-291.
31. Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. 2007;157: 371-382.
32. Vierimaa O, Georgitsi M, Lehtonen R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006; 312:1228-1230.
33. Coulam CB, Annegers JF, Abboud CF, Laws ER Jr, Kurland LT. Pituitary adenoma and oral contraceptives: a case-control study. Fertil Steril. 1979;31:25-28.
34. Coulam CB, Annegers JF, Kranz JS. The association between pituitary adenomas and chronic anovulation syndrome. Am J Obstet Gynecol. 1982;143:319-324.
35. Anonymous. Pituitary adenomas and oral contraceptives: a multicenter case-control study. Fertil Steril. 1983;39:753-760.
36. Taler SJ, Coulam CB, Annegers JF, Brittain EH. Case-control study of galactorrhea and its relationship to the use of oral contraceptives. Obstet Gynecol. 1985;65:665-668.
37. Coogan PF, Baron JA, Lambe M. Parity and pituitary adenoma risk. J Natl Cancer Inst. 1995;87:1410-1411.
38. Original Data Depositor-2001 Census. Census Area Statistics (Scotland) and Census Area Statistics (England & Wales) [computer file]. 2001. ESRC/JISC Census Programme, Census Dissemination Unit, MIMAS (University of Manchester)/Census Interaction Data Service (University of Leeds).